Drug Type mRNA |
Synonyms AD 15, AD15 |
Target- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization ADvantage Therapeutics, Inc.Startup |
Active Organization ADvantage Therapeutics, Inc.Startup |
Inactive Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Alzheimer Disease | Discovery | US | ADvantage Therapeutics, Inc.Startup | 17 Jul 2024 |